Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
2006 1
2007 2
2009 3
2010 13
2011 14
2012 16
2013 11
2014 14
2015 13
2016 17
2017 15
2018 14
2019 14
2020 21
2021 14
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

156 results
Results by year
Filters applied: . Clear all
Page 1
[Pharmacovigilance update].
Ekobena P, Ivanyuk A, Livio F. Ekobena P, et al. Rev Med Suisse. 2021 Jan 13;17(720-1):80-84. Rev Med Suisse. 2021. PMID: 33443836 Review. French.
Ranitidine: global market withdrawal due to contamination with nitrosamines. Ulipristal for uterine fibroids : market withdrawal due to risk of severe liver injury. ...
Ranitidine: global market withdrawal due to contamination with nitrosamines. Ulipristal for uterine fibroids : market withdrawal due …
[Pharmacovigilance update].
Abo Loha C, Livio F. Abo Loha C, et al. Rev Med Suisse. 2019 Jan 9;15(N° 632-633):92-95. Rev Med Suisse. 2019. PMID: 30629378 Review. French.
Saccharomyces boulardii : risk of fungemia in frail patients. Ulipristal : risk of hepatotoxicity. Daclizumab : early withdrawal from the market as risks clearly outweigh benefits. ...
Saccharomyces boulardii : risk of fungemia in frail patients. Ulipristal : risk of hepatotoxicity. Daclizumab : early withdrawal from …
Emergency Contraception.
Batur P, Kransdorf LN, Casey PM. Batur P, et al. Mayo Clin Proc. 2016 Jun;91(6):802-7. doi: 10.1016/j.mayocp.2016.02.018. Mayo Clin Proc. 2016. PMID: 27261868 Free article. Review.
There are 4 approved EC options in the United States. Although ulipristal acetate requires a provider's prescription, oral levonorgestrel (LNG) is available over the counter for women of all ages. ...Women who weigh more than 75 kg or have a body mass index greater than 25 …
There are 4 approved EC options in the United States. Although ulipristal acetate requires a provider's prescription, oral levonorges …
Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis.
Glasier AF, Cameron ST, Fine PM, Logan SJ, Casale W, Van Horn J, Sogor L, Blithe DL, Scherrer B, Mathe H, Jaspart A, Ulmann A, Gainer E. Glasier AF, et al. Lancet. 2010 Feb 13;375(9714):555-62. doi: 10.1016/S0140-6736(10)60101-8. Epub 2010 Jan 29. Lancet. 2010. PMID: 20116841 Clinical Trial.
In 203 women who received emergency contraception between 72 h and 120 h after sexual intercourse, there were three pregnancies, all of which were in the levonorgestrel group. The most frequent adverse event was headache (ulipristal acetate, 213 events [19.3%] in 11 …
In 203 women who received emergency contraception between 72 h and 120 h after sexual intercourse, there were three pregnancies, all of whic …
Choice of contraceptives.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2018 Oct 8;60(1557):161-168. Med Lett Drugs Ther. 2018. PMID: 30335731 No abstract available.
Preoperative medical therapy before surgery for uterine fibroids.
Lethaby A, Puscasiu L, Vollenhoven B. Lethaby A, et al. Cochrane Database Syst Rev. 2017 Nov 15;11(11):CD000547. doi: 10.1002/14651858.CD000547.pub2. Cochrane Database Syst Rev. 2017. PMID: 29139105 Free PMC article. Review.
GnRHa versus other medical therapies GnRHa was associated with a greater reduction in uterine volume (-47% with GnRHa compared to -20% and -22% with 5 mg and 10 mg ulipristal acetate) but was more likely to cause hot flushes (OR 12.3, 95% CI 4.04 to 37.48; 5 studies; 183 p …
GnRHa versus other medical therapies GnRHa was associated with a greater reduction in uterine volume (-47% with GnRHa compared to -20% and - …
Limbo.
Schorge JO. Schorge JO. Obstet Gynecol. 2018 Jun;131(6):959-960. doi: 10.1097/AOG.0000000000002610. Obstet Gynecol. 2018. PMID: 29688918 No abstract available.
Interventions for emergency contraception.
Shen J, Che Y, Showell E, Chen K, Cheng L. Shen J, et al. Cochrane Database Syst Rev. 2017 Aug 2;8(8):CD001324. doi: 10.1002/14651858.CD001324.pub5. Cochrane Database Syst Rev. 2017. PMID: 28766313 Free PMC article. Updated. Review.
The primary review outcome was observed number of pregnancies. Side effects and changes of menses were secondary outcomes. MAIN RESULTS: We included 115 trials with 60,479 women in this review. ...Comparative effectiveness of Cu-IUD versus mifepristoneThere was no conclusi …
The primary review outcome was observed number of pregnancies. Side effects and changes of menses were secondary outcomes. MAIN RESUL …
Birth Control Pills and Thrombotic Risks: Differences of Contraception Methods with and without Estrogen.
Rott H. Rott H. Hamostaseologie. 2019 Feb;39(1):42-48. doi: 10.1055/s-0039-1677806. Epub 2019 Jan 22. Hamostaseologie. 2019. PMID: 30669160 Review.
Emergency contraceptions, which do not contain EE, but only levonorgestrel or ulipristal acetate, do not result in a higher risk for VTE. Oral desogestrel- or levonorgestrel-only contraceptives, intrauterine device, and etonogestrel implants are the contraception of choice …
Emergency contraceptions, which do not contain EE, but only levonorgestrel or ulipristal acetate, do not result in a higher risk for …
Ulipristal acetate for emergency contraception.
Snow SE, Melillo SN, Jarvis CI. Snow SE, et al. Ann Pharmacother. 2011 Jun;45(6):780-6. doi: 10.1345/aph.1P704. Epub 2011 Jun 10. Ann Pharmacother. 2011. PMID: 21666089 Review.
Commonly reported adverse effects associated with ulipristal acetate in trials included headache, breast tenderness, nausea, and abdominal pain. ...Because ulipristal is available only via prescription, it may be covered by insurance. ...
Commonly reported adverse effects associated with ulipristal acetate in trials included headache, breast tenderness, na …
156 results